[Seite 87↓]

Literatur

Acuna-Castroviejo, D., Coto-Montes, A., Monti, M.G., Ortiz, G.G., and Reiter, R.J. (1997). Melatonin is protective against MPTP-induced striatal and hippocampal lesions. Life Sci. 60, 23-29.

Adams, J.M., and Cory, S. (1998). The Bcl-2 protein family: Arbiters of cell survival. Science 281, 1322-1326.

Alkayed, N.J., Murphy, S.J., Traystman, R.J., and Hurn, P.D. (2000). Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. Stroke 31, 161-168.

Antolin, I., Rodriguez, C., Sainz, R.M., Mayo, J.C., Uria, H., Kotler, M.L., Rodriguez-Colunga, M.J., Tolivia, D., and Menendez-Palaez, A. (1996). Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB J. 10, 882-890.

Barsacchi, R., Kusmic, C., Damiani, E., Carloni, P., Greci, L., and Donato, L. (1998). Vitamin E consumption induced by oxidative stress in red blood cells is enhanced by melatonin and reduced by N-acetylserotonin. Free Radic. Biol. Med. 24, 1187-1192.

Behan, W.M.H., McDonald, M., Darlington, L.G., and Stone, T.W. (1999). Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl. Brit. J. Pharmacol. 128, 1754-1760.

Behl, C (2002) . Oestrogen as a neuroprotective hormone. Nature Rev. 3, 433-442.

Behl, C., Skutella, T., Lezoualc’h, F., Post, A., Widmann, M., Newton, C.J., and Holsboer, F. (1997). Neuroprotection against oxidative stress by estrogens: Structure-activity relationship. Mol. Pharmacol. 51, 535-541.

Behl, C., and Holsboer, F. (1999). The female sex hormone oestrogen as a neuroprotectant. Trends in Pharmacol. Sci. 20, 441-444.

Behl, C., Davis, J.B., Lesley, R., and Schubert, D. (1994). Hydrogen peroxide mediates amyloid protein toxicity. Cell 77, 817-827.

Benitez-King, G., and Anton-Tay, F. (1993). Calmodulin mediates melatonin cytoskeletal effects. Experientia 49, 635-641.

Bertrand, R., Solary, E., O’Connor, P., Kohn, K.W., and Pommier, Y. (1994). Induction of a common pathway of apoptosis by staurosporine. Exp. Cell. Res. 211, 314-321.

Beyer, C., and Raab, H. (1998). Nongenomic effects of oestrogen: embryonic mouse midbrain neurones respond with a rapid release of calcium from intracellular stores. Eur. J. Neurosci. 10, 255-262.

Bhargava, V., Kell, D.L., van de Rijn, M., and Warnke, R.A. (1994). Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positively. Am. J. Pathol. 145, 535-540.

Bi, R., Broutman, G., Foy, M.R., Thompson, R.F., and Baudry, M. (2000). The tyrosine kinase and mitogen-activated protein kinase pathways mediate multiple effects of estrogen in hippocampus. Proc. Natl. Acad. Sci. USA 97, 3602-3607.

Bicknell, R.J. (1998). Sex-steroid actions on neurotransmission. Curr. Opin. Neurol. 11, 667-671.

Birge, S.J. (1996). Is there a role for estrogen replacement therapy in the prevention and treatment of dementia? J. Am. Geriatr. Soc. 44, 865-870.

Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P., and Lipton, S.A. (1995). Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartat or nitric oxide / superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. USA. 92, 7162-7166.


[Seite 88↓]

Bonnefont, A.B., Munoz, F.J., and Inestrosa, N.C. (1998). Estrogen protects neuronal cells from the cytotoxicity induced by acetylcholinesterase-amyloid complexes. FEBS Lett. 441, 220-224.

Brewer, G.J. (1995). Serum-free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum and dendate gyrus. J. Neurosci. Res. 42, 674-683.

Brines, M.L., Gezzi, P., Keenan, S., Agnello, D., de Lanerolle, N.C., Cerami, C., Itri, L.M., and Cirami, A. (2000). Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. USA 97, 10526-10531.

Bruer, U., Weih, M.K., Isaev, N.K., Meisel, A., Ruscher, K., Bergk, A., Trendelenburg, G., Wiegand, F., Victorov, I.V., and Dirnagl, U. (1997). Induction of tolerance in rat cortical neurons: hypoxic preconditioning. FEBS Lett. 414, 117-121.

Brusco, l., Marquez, M., and Cardinali, D.P. (1998) Monozygotic twins with Alzheimer’s disease treated with melatonin: case report. J. Pineal Res. 25, 260-263.

Brusco, l., Marquez, M., and Cardinali, D.P. (2000) Melatonin treatment stabilizes chronobiologic and cognitive symptoms of Alzheimer’s disease. Neuroendocrinol. Lett. 21, 39-42.

Busser, J., Geldmacher, D.S., and Herrup, K. (1998). Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer’s disease brain. J. Neurosci. 18, 2801-2807.

Cardinali, D.P., Brusco, L.I., Liberczuk, C., and Furio, A.M. (2002) The use of melatonin in Alzheimer´s disease. Neuroendocrinol. Lett. 23 Suppl. 1 , 20-23.

Cazevieille, C., Safa, R., and Osborne, N.N. (1997). Melatonin protects primary neuronal cultures of rat cortical neurones from NMDA excitotoxicity and hypoxia / reoxygenation. Brain Res. 768, 120-124.

Celik, M., Gökmen, N., Erbayraktar, S., Akhisaroglu, M., Konakç, S., Ulukus, C., Genc, S., Genc, K., Sagiroglu, E., Ceramil, A., and Brines, M . (2002). Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury . Proc. Natl. Acad. Sci. USA 99, 2258-2263.

Chen, J., Nagayama, T., Jin, K., Stetler, R.A., Zhu, R.L., Graham, S.H., and Simon, R.P. (1998). Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J. Neurosc. 18, 4914-4928.

Chen, S.T., and Chuang, J.I. (1999). The antioxidant melatonin reduces cortical neuronal death after intrastriatal injection of kainate in the rat. Exp. Brain Res. 124, 241-247.

Chen, Z.J., Yu, L., and Chang, C.H. (1998). Stimulation of membrane-bound guanylate cyclase activity by 17 β -estradiol. Biochem. Biophys. Res. Comm. 252, 639-642.

Cho, S., Joh, T:H:, Baik, H.W., Dibinis, C., and Volpe, B.T. (1997) Melatonin administration protects CA1 hippocampal neurons after transient forebrain ischemia in rats. Brain Res. 755, 335-338.

Cohen, G., and Heikkila, R.E. (1974). The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J. Biol. Chem. 249, 2447-2452.

Cohen, J.J. (1991). Programmed cell death in the immune system. Adv. Immunol. 50, 55-85.

Copani, A., Bruno, V., Battaglia G., Leanza, G., Pellitteri, R., Russo, A., Stanzani, S., and Nicoletti, F. (1995). Activation of metabotropic glutamate receptor protects cultured neurons against apoptosis induced by β -amyloid peptide. Mol. Pharmacol. 47, 890-897.

Copin, J.C., Li, Y., Reola, L., and Chan P. H. (1998). Trolox and 6,7-dinitroquinoxaline-2,3-dione prevent necrosis but not apoptosis in cultured neurons subjected to oxygen deprivation. Brain Res. 784, 25-36.

Costa, M.M., Reus, V.I., Wolkowitz, O.M., Manfredi, F., and Lieberman, M. (1999). Estrogen replacement therapy and cognitive decline in memory-impaired post-menopausal women. Biol. Psychiatry. 46, 182-188.


[Seite 89↓]

Dabbeni-Sala, F., Floreani, M., Franceschini, D., Skaper, S.D., and Giusti, P. (2001). Kainic acid in duces selective mitochondrial oxidative phosphorylation enzyme dysfunction in cerebellar granule neurons: protective effects of melatonin and GSH ethyl ester. FASEB J. 15, 1786-1788.

Dawson, T.M. (2002). Preconditioning-mediated neuroprotection through erythropoietin. Lancet 359, 96-97.

Deveraux, Q.L., and Reed, J.C. (1999). IAP family proteins - suppressors of apoptosis. Genes Dev. 13, 239-252.

Digicaylioglu, M., and Lipton, S.A. (2001). Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF- κ B signalling cascades. Nature 412, 641-647.

Dodel, R.C., Du, Y., Bales, K.R., Ling, Z., Carvey, P.M., and Paul, S.M. (1999). Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death. Mol. Brain Res. 64, 141-148.

Dubal, D.B., Kashon, M.L., Pettigrew, L.C., Ren, J.M., Finklestein, S.P., Rau, S.W., and Wise, P.M. (1998). Estradiol protects against ischemic injury. J. Cereb. Blood. Flow Metab. 18, 1253-1258.

Dubal, D.B., Shughrue, P.J., Wilson, M.E., Merchenthaler, I., and Wise, P.M. (1999). Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J. Neurosci. 19, 6385-6393.

Dubal, D.B., Zhu, H., Yu, J., Rau, S.W., Shugrue, P.J., Merchenthaler, I., Kindy, M.S., and Wise, P.M. (2001) Estrogen receptor α , not β , is a critical link in estradiol-mediated protection against brain injury. Proc. Natl. Acad. Sci. USA 98, 1952-1957.

Endres, M., Namura, S., Shimizu-Sasamata, M., Waeber, C., Zhang, L., Gómez-Isla, T., Hyman, B.T., and Moskowitz, M.A. (1998). Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J. Cerebr. Blood Flow Metab. 18, 238-247.

Ellis, R.E., Yuan, J.Y., and Horvitz, H.R. (1991). Mechanisms and functions of cell death. Annu. Rev. Cell. Biol. 7, 663-698.

Fadok, V.A., Voelker, D.R., Campbell, P.A., Cohen, J.J., Bratton, D.L., and Henson, P.M. (1992). Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148, 2207-2216.

Falcieri, E., Martelli, A.M., Bareggi, R., Cataldi, A., and Cocco, L. (1993). The protein kinase inhibitor staurosporine induces morphological changes typical of apoptosis in MOLT-4 cells without concomitant DNA fragmentation. Biochem. Biophys. Res. Comm. 193, 19-25.

Filipkowski, R.K., Hetman, M. Kaminska, B. and Kaczmarek, L. (1994). DNA fragmentation in rat brain after intraperitoneal administration of kainate. NeuroReport. 5, 1538-1540.

Fink, K., Zhu, J., Namura, S., Shimizu-Sasamata, M., Endres, M., Ma, J., Dalkara, T., Yuan, J., and Moskowitz, M.A. (1998). Prolonged therapeutic window for ischemic brain damage caused by delayed caspase activation. J. Cerebr. Blood Flow Metab. 18, 1071-1076.

Fisher, A., Mantione, C.R., Abraham, D.J., and Hanin, I. (1982). Long-term central cholinergic hypofunction in mice by ethylcholine aziridinium ion (AF64A) in vivo. J. Pharmacol. Exp. Ther. 222, 140-145.

Floreani, M., Skaper, S.D., Facci, L., Lipartiti, M., and Giusti, P. (1997). Melatonin maintains glutathione homeostasis in kainic acid-exposed rat brain tissues. FASEB. J. 11, 1309-1315.

Garcia-Segura, L.M., Cardona-Gomez, P., Naftolin, F., and Chowen, J.A. (1998). Estradiol upregulates Bcl-2 expression in adult brain neurons. NeuroReport 9, 593-597.

Gazzaley, A.H., Weiland, N.G., McEwen, B.S., and Morrison, J.H. (1996). Differential regulation of NMDAR1 mRNA and protein by estradiol in the rat hippocampus. J. Neurosci. 16, 6830-6838.

Gerschenson, L.E., and Rotello, R.J. (1992). Apoptosis: A different type of cell death. FASEB J. 6, 2450-2455.


[Seite 90↓]

Gibb, J.W., Bush, L., and Hanson G.R. (1997). Exacerbation of methamphetamine-induced neuro chemical deficits by melatonin. J. Pharmacol. Exp. Ther. 283, 630-635.

Gilad, E., Wong, H.R., Zingarelli, B., Virág, L., O’Connor, M., Salzman, A.L., and Szabó, C. (1998). Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NF κ B activation. FASEB J. 12, 685-693.

Giusti, P., Lipartiti, M., Franceschini, D., Schiavo, N., and Floreani, M. (1996). Neuroprotection by melatonin from kainate-induced excitotoxicity in rats. FASEB J. 10, 891-896.

Glücksmann, A. (1951). Cell deaths in normal vertebrate ontogeny. Biol. Rev. 26, 59-86.

Golstein, P., Ojcius, D.M., Young, J.D. (1991). Cell death mechanisms and the immune system. Immunol. Rev. 121, 29-65.

Goodman, Y., Bruce, A.J., Cheng, B., and Mattson, M.P. (1996). Estrogens attenuate and corticosteron exacerbates excitotoxicity, oxidative injury, and amyloid β -peptide toxicity in hippocampal neurons. J. Neurochem. 66, 1836-1844.

Gottron, F.J., Ying, H.S., and Choi, D.W. (1997). Caspase inhibition selectively reduces the apoptotic component of oxygen-glucose deprivation-induced cortical neuronal cell death. Mol. Cell. Neurosci. 9, 159-169.

Gridley, K.E., Green, P.S., and Simpkins, J.W. (1997). Low concentration of estradiol reduce β -amyloid (25-35)-induced neurotoxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells. Brain Res. 778, 158-165.

Grodstein, F., Stampfer, M.J., Manson, J.E., Colditz, G.A., Willet, W.C., Rosner, B., Speizer, F.E., and Hennekens, C.H. (1996). Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N. Engl. J. Med. 335, 453-461.

Gschwind, M., and Huber, G. (1995). Apoptotic cell death induced by β -amyloid1-42 is cell type dependent. J. Neurochem. 65, 292-300.

Gu, Q., Korach, K.S., and Moss, R.L. (1999). Rapid action of 17 β -estradiol on kainate-induced currents in hippocampal neurons lacking intracellular estrogen receptors. Endocrinology 140, 660-666.

Gulyaeva, N.V., Lazareva, N.A., Libe, M.L., Mitrokhina, M.V., Yu, M., and Walsh, T.J. (1996). Oxidative stress in the brain following intraventricular administration of ethylcholine aziridinium (AF64A). Brain Res. 726, 174-180.

Hanin, I. (1996 ). The AF64A model of cholinergic hypofunction: An update. Life Sci. 58, 1955-1964.

Harms, C., Lautenschlager, M., Bergk, A., Freyer, D., Weih, M., Dirnagl, U., Weber, J.R., and Hörtnagl, H. (2000). Melatonin is protective in necrotic but not in caspase-dependent, free radical-independent apoptotic neuronal cell death in primary neuronal cultures. FASEB J. 14, 1814-1824.

Harms, C., Lautenschlager, M., Bergk, A., Katchanov, J., Freyer, D., Kapinya, K., Herwig, U., Megow, D., Dirnagl, U., Weber, J.R., and Hörtnagl, H. (2001). Differential mechanisms of neuroprotection by 17 β -Estradiol in apoptotic versus necrotic neurodegeneration. J. Neurosc. 21 (8), 2600-2609.

Harms, C. & Katchanov, J., Hauck, L., Herwig, U., Freyer, D., Engel, F., v. Harsdorf, R., Bhide, B.G., Dirnagl, U., Hörtnagl, H., and Endres, M. (2002). Temporal coordination in the progression of neurons into G1/S-phase and onset of delayed neuronal apoptosis. Manuscript submitted.

Hengartner, M.O., and Horvitz, H.R. (1994). Programmed cell death in caenorrhabditis elegans. Curr. Opin. Genet. Div. 4, 581-586.

Hogervorst, E., and Smith, D. (2002). The interaction of serum folate and estradiol levels in Alzheimer´s disease. Neuroendocrinol. Lett. 23, 155-160.

Honda, K., Sawada, H., Kihara, T., Urushitani, M., Nakamizo, T., Akaike, A., and Shimohama, S. (2000) Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons. J. Neurosci. Res. 60, 321-327.


[Seite 91↓]

Hörtnagl, H., Berger, M.L., Reither, H., and Hornykiewicz, O. (1991). Cholinergic deficit induced by ethylcholine aziridinium (AF64A) in rat hippocampus: Effect on glutamatergic systems. Naunyn-Schmiedeberg’s Arch. Pharmacol. 344, 213-219.

Huerto-Delgadillo, L., Anton-Tay, F., and Benitez-King, G. (1994). Effects of melatonin in microtubule assembly dependend on hormone concentration: role of melatonin as a calmodulin antagonist. J. Pineal Res. 17, 55-62.

Hurn, P.D., and MacRae, I.M. (2000). Estrogen as a neuroprotectant in stroke. J. Cereb. Blood Flow. Metab. 20, 631-652.

Hyder, S.M., Chiappetta, C., and Stancel, G.M. (1999). Interaction of human estrogen receptors α and β with the same naturally occurring estrogen response elements. Biochem. Pharmacol. 57, 597-601.

Iacovitti, L., Stull, N.D., and Johnston, K. (1997). Melatonin rescues dopamine neurons from cell death in tissue culture models of oxidative stress. Brain Res. 768, 317-326.

Ianas, O., Olinescu, R. and Badescu, I. (1991). Melatonin involvement in oxidative processes. Endocrinologie 29, 147-153.

Jin, B.K., Shin, D.Y., Jeong, M.Y., Gwag, M.R., Baik, H.W., Yoon, K.S., Cho, Y.H., Joo, W.S., Kim, Y.S., and Baik, H.H. (1998). Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats. Neurosci. Lett. 245, 61-64.

Kabuto, H., Yokoi, I., and Ogawa, N. (1998). Melatonin inhibits iron-induced epileptic discharges in rats by suppressing peroxidation. Epilepsia 39, 237-243.

Kahlert, S., Nuedling, S., van Eickels, M., Vetter, H., Meyer, R., and Grohé, C. (2000). Estrogen receptor α rapidly activates the IGF-1 receptor pathway. J. Biol. Chem. 275, 18447-18453.

Katchanov, J. & Harms, C., Gertz, K., Hauck, L., Waeber, C., Hirt, L., Priller, J., v. Harsdorf, R., Brück, W., Hörtnagl, H., Dirnagl, U., Bhide, P.G., and Endres, M. (2001). Mild cerebral ischemia induces loss of cyclin-dependent kinase inhibitors and activation of cell cycle machinery before delayed neuronal cell death. J. Neurosci. 21, 5045-5053.

Keller, J.N., Germeyer, A., Begley, J.G., and Mattson, M.P. (1997). 17 β -Estradiol attenuates oxidative impairment of synaptic Na+/K+-ATPase activity, glucose transport, and glutamate transport induced by amyloid β -peptide and iron. J. Neurosci. Res. 50, 522-530.

Kerr, J.F.R. (1971). Shrinkage necrosis: A distinct mode of cellular death. J. Pathol. 105, 13-20.

Kerr, J.F.R., and Harmon, B.V. (1991). Definition and incidence of apoptosis: An historical perspective. In: Tomei, L.D., and Cope, F.O., eds. Apoptosis: The molecular basis of cell death. Cold Spring Harbor, NY. Cold Spring Harbor Laboratory Press. 3, 5-29.

Kerr, J.F.R., Wyllie, A.H., Currie, A.R. (1972). Apoptosis: A basic biological phenomenon with wideranging implication in tissue kinetics. Br. J. Cancer 26, 239-257.

Kim, Y.S., Joo, W.S., Jin, B., Cho, Y.H., Baik, H.H., and Park, C.W. (1998). Melatonin protects 6-OHDA-induced neuronal death of nigrstriatal dopaminergic system. NeuroReport 9, 2387-2390.

Kölker, S., Ahlemeyer, B., Krieglstein, J., and Hoffmann, G.F. (2001). Contribution of reactive oxygen species to 3-hydroxyglutarate neurotoxicity in primary neuronal cultures from chick embryo telencephalons. Pediatric Res. 50, 76-82.

Koh, J.Y., and Choi D.W. (1987). Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Meth. 20, 83-90.

Koh, J.Y., Wie, M.B., Gwag, B.J., Seni, S.L., Canzoniero, L.M., Demaro, J., Csernansky, C., and Choi, D.W. (1995). Staurosporine-induced neuronal apoptosis. Exp. Neurol. 135, 153-159.

Kothakota, S., Azuma, T., Reinhard, C., Klippel, A., Tang, J., Chu, K., McGarry, T.J., Kirschner, M.W., Koths, K., Kwiatkowski, D.J., and Williams L.T. (1997). Caspase-3 generated fragment of gelsolin: effector of morphological change in apoptosis. Science 278, 294-298.


[Seite 92↓]

Kuiper, G.G.J.M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., and Gustafsson, J.A. (1997). Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β . Endocrinology 138, 863-870.

Kuiper, G.G.J.M., Shughrue, P.J., Merchenthaler, I., and Gustafsson, J.-A. (1998). The estrogen receptor β subtype: A novel mediator of estrogen action in neuroendocrine systems. Frontiers in Neuroendocrinol. 19, 253-286.

Lafferty, F.W., and Fiske, M.E. (1994). Postmenopausal estrogen replacement: a long term cohort study. Am. J. Med. 97, 66-77.

Laflamme, N., Nappi, R.E., Drolet, G., Labrie, C., and Rivest, S. (1998). Expression and neuropeptidergic characterization of estrogen receptors (ER α and ER β ) throughout the rat brain: anatomical evidence of distinct roles of each subtype. J. Neurobiol. 36, 357-378.

Lapin, I.P., Mirzaev, S.M., Ryzov, I.V., and Oxenkrug, G.F. (1998). Anticonvulsant activity of melatonin against seizures induced by quinolinate, kainate, glutamate, NMDA, and pentylenetetrazole in mice. J. Pineal Res. 24, 215-218.

Lassmann, H., Bancher, C., Breitkopf, H., Wegiel, J., Bobinski, M., Jellinger, K., and Wisniewski, H.M. (1995). Cell death in Alzheimer’s disease evaluated by DNA fragmentation in situ. Acta Neuropath. 89, 35-41.

Lautenschlager, M., Arnswald, A., Freyer, D., Weber, J. R., and Hörtnagl, H. (1997). The AF64A model of cholinergic hypofunction: Role of nitric oxide in AF64A-mediated neurodegeneration. In: Advances in Behavioral Biology Vol 49: Progress in Alzheimer’s and Parkinson’s Diseases (Fisher, A., Yoshida, M., and Hanin, I., eds) pp. 681-686, Plenum Publishing Corporation, New York, USA

Lautenschlager, M., Onufriev, M.V., Gulyaeva, N.V., Harms, C., Freyer, D., Sehmsdorf, U.-S., Ruscher, K., Moiseeva, Y.V., Arnswald, A., Victorov, I., Dirnagl, U., Weber, J.R., and Hörtnagl, H. (2000). Role of nitric oxide in the ethylcholine aziridinium (AF64A) model of delayed apoptotic neurodegeneration in vivo and in vitro. Neuroscience 97, 383-393.

Lee, S.J., and McEwen, B.S. (2001). Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 41, 569-591.

Leist, M., and Jäättelä, M. (2001). Four deaths and a funeral: From caspases to alternative mechanisms. Nature Rev, 2, 3-10.

Lezoualc´h, F., Skutella, T., Widmann, M., and Behl, C. (1996). Melatonin prevents oxidative stress-induced cell death in hippocampal cells. NeuroReport 7, 2071-2077.

Linnik, M.D., Zobrist, R.H., and Hatfield, M.D. (1993). Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke 24, 2002-2008.

Lotharius, J., Dugan, L.L., and O’Malley, K.L. (1999). Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J. Neurosci. 19, 1284-1293.

MacManus, J.P., Buchan, A.M., Hill, I.E., Rasquinha, I., and Preston, E. (1993). Global ischemia can cause DNA fragmentation in rat brain. Neurosci. Lett. 164, 89-92.

Majno, G., and Joris, I. (1995). Apoptosis, oncosis and necrosis. An overview of cell death. Am. J. Pathol. 146, 3-15.

Manev, H., Uz, T., Kharlamov, A., and Joo, J.-Y. (1996). Increased brain damage after stroke or excitoxic seizures in melatonin-deficient rats. FASEB J. 10, 1546-1551.

Martin, L.J., Al-Abdulla, N.A., Brambrink, A.M., Kirsch, J.R., Sieber, F.E., and Portera-Cailliau, C. (1998). Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis. Brain Res. Bulletin 46 (4), 281-309.

Mattson, M.P., Robinson. N., and Guo, Q. (1997). Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. NeuroReport 8, 3817-3821.


[Seite 93↓]

Mayo, J.C., Sainz, R.M., Antolin, I., and Rodriguez, C. (1999). Ultrastructural confirmation of neuronal protection by melatonin against the neurotoxin 6-hydroxydopamine cell damage. Brain Res. 818, 221-227.

Mechoulam, R., Panikashvili, D., and Shohami, E. (2002). Cannabinoids and brain injury: therapeutic implications. Trends Mol. Med. 8, 58-61.

Medina-Navarro, R., Duran-Reyes, G., and Hicks, J.J. (1999). Pro-oxidating properties of melatonin in the in vitro interaction with the singlet oxygen. Endocr. Res. 25, 263-280.

Mehmet, H. (2000) Caspases find a new place to hide. Nature 403, 29-30.

Melchiorri, D., Reiter, R.J., Sewerynek, E., Chen, L.D., and Nistico, G. (1995). Melatonin reduces kainate-induced lipid peroxidation in homogenates of different brain regions. FASEB J. 9, 1205-1210.

Mermelstein, P.G., Becker, J.B., and Surmeier, D.J. (1996). Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. J. Neurosci. 16, 595-604.

Mevissen, M., and Ebert, U. (1998). Anticonvulsant effects of melatonin in amygdala-kindled rats. Neurosci. Lett. 257, 13-16.

Mochizuki, H., Goto, K., Mori, H., and Mizuno, Y (1996). Histochemical detection of apoptosis in Parkinson’s disease. J. Neurol. Sci. 137, 120-123.

Mohan, N., Sadeghi, K., Reiter, R.J., and Meltz, M.L. (1995). The neurohormone melatonin inhibits cytokine, mitogen and ionizing radiation induced NF- κ B. Biochem. Mol. Biol. Int. 37, 1063-1070.

Mook-Jung, I., Joo, I., Sohn, S., Kwon, H.J., Huh, K., and Jung, M.W. (1997). Estrogen blocks neurotoxic effects of β -amyloid (1-42) and induces neurite extension on B103 cells. Neurosci. Lett. 235, 101-104.

Moosmann, B., and Behl, C. (1999). The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc. Natl. Acad. Sci., USA 96, 8867-8872.

Mulnard, R.A., Cotman, C.W., Kawas, C., van Dyck, C.H., Sano, M., Doody, R., Koss, E., Pfeiffer, E., Jin, S., Gamst, A., Grundman, M., Thomas, R., and Thal, L.J. (2000). Estrogen replacement therapy for treatment of mild to moderate Alzheimer’s disease. A randomized controlled trial. JAMA 283, 1007-1015.

Nakagawa, T., and Yuan, J. (2000). Cross-talk between two cysteine protease families: Activation of caspase-12 by calpain in apoptosis. JCB 150, 887-894.

Namura, S., Zhu, J., Fink, K., Endres, M., Srinivasan, A., Tomaselli, K.J., Yuan, J., and Moskowitz, M.A. (1998). Activation and cleavage of caspase-3 in apoptosis by experimental cerebral ischemia. J. Neurosc. 18, 3659-3668.

Nath, R., Raser, K.J., Stafford, D., Hajimohammadreza, I., Posener, A., Allen, H., Talanian, R.V., Yuen, P., Gilbertsen, R.B., and Wang, K.K. (1996). Non-erythroid α -spectrin breakdown by calpain and interleukin 1 β -converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. Biochem. J. 319, 683-690.

Nathan, L., and Chaudhuri, G. (1998). Antioxidant and prooxidant actions of estrogens: potential physiological and clinical implications. Semin. Reprod. Endocrinol. 16, 309-314.

Nicotera, P., Leist, M., and Manzo, L. (1999). Neuronal cell death: A demise with different shapes. Trends Pharmacol. Sci. 20, 46-51.

Oberhammer, F., Wilson, J.W., Dive, C., Morris, I.D., Hickmann, J.A., Wakeling, A.F., Walker, P.R., and Sikorska, M. (1993). Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. 12, 3679-3684.


[Seite 94↓]

Oppenheim, R.W. (1991). Cell death during development of the nervous system. Annu. Rev. Neurosc. 14, 453-501.

Osuga, H., Osuga, S., Wang, F., Hogan, M.J., Slack, R.S., Hakim, A.M., Ikeda, J.-E., and Park, D.S. (2000). Cyclin-dependent kinases as a therapeutic target for stroke. Proc. Natl. Acad. Sci. USA 97, 10254-10259.

Otsuki, Y., Misaki, O., Sugimoto, O., Ito, Y., Tsujimoto, Y., and Akao Y (1994). Cyclic bcl-gene expression in humane uterine endometrium during menstrual cycle. Lancet 344, 28-29.

Paech, K., Webb, P., Kuiper, G.G.J.M., Nilsson, S., Gustafsson, J.A., Kushner, P.J., and Scanlan, T.S. (1997). Differential ligand activation of estrogen receptors ER α and ER β at AP1 sites. Science 277, 1508-1510.

Paganini-Hill, A., and Henderson, V.W. (1994). Estrogen deficiency and risk of Alzheimer’s disease in women. Am. J. Epidemiol. 140, 256-261.

Panikashvili, D., Simeonidou, C., Ben-Shabat, S., Hanuš. L., Breuer, A., Mechoulam, R., and Shohami, E. (2001). An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 413, 527-531.

Paolini, M., Pozzetti, L., Pedulli, G.F., Marchesi, E., and Cantelli-Forti, G. (1999). The nature of prooxidant activity of vitamin C. Life Sci. 64, 273-278.

Pappolla, M.A., Sos, M., Omar, R.A., Blick, R.J., Hickson-Blick, D.L.M., Reiter, R.J., Efthimiopoulos, S., and Robakis, N.K. (1997). Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J. Neurosci. 17, 1683-1690.

Pappolla, M., Bozner, P., Soto, C., Shao, H., Robakis, N.K., Zagorski, M., Frangione, B., and Ghiso, J. (1998). Inhibition of Alzheimer β -fibrillogenesis by melatonin. J. Biol. Chem. 273, 7185-7188.

Park, D.S., Farinelli, S.E., and Greene, L.A. (1996). Inhibitors of cyclin-dependent kinases promotes survival of postmitotic neuronally differentiated PC12 cells and sympathetic neurons. J. Biol. Chem. 271, 8161-8169.

Park, D.S., Levine, B., Ferrari, G., and Greene, L.A. (1997). Cyclin dependent kinase inhibitors and dominant negative cyclin dependent kinase 4 and 6 promote survival of NGF-deprived sympathetic neurons. J. Neurosci. 17, 8975-8983.

Park, D.S., Morris, E.J., Padmanabhan, J., Shelanski, M.L., Geller, H.M., and Greene, L.A. (1998). Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents. J. Cell Biol. 143, 457-467.

Pike, C.J. (1999). Estrogen modulates neuronal Bcl-xL expression and β -amyloid-induced apoptosis: relevance to Alzheimer’s disease. J. Neurochem. 72, 1552-1563.

Pollard, H., Charriaut-Marlangue, C., Cantagrel, S., Represa, A., Robain, O., Moreau, J. and Ben-Ari, Y. (1994). Kainate-induced apoptotic cell death in hippocampal neurons. Neuroscience 63, 7-18.

Raff, M.C., Barres, B., Burne, J., Coles, H., Ishizaki, Y., and Jacobson, M. (1993). Programmed cell death and control of cell survival: Lessons from the central nervous system. Science 262, 695-700.

Rao, R.V., Hermel, E., Castro-Obregon, S., del Rio, G., Ellerby, L.M., Ellerby, H.M., and Bredesen, D.E. (2001) Coupling endoplasmic reticulum stress to cell death programm. Mechanism of caspase activation. J. Biol. Chem. 276, 33869-33874.

Regan, R.F., and Guo, Y. (1997). Estrogens attenuate neuronal injury due to hemoglobin, chemical hypoxia, and excitatory amino acids in murine cortical cultures. Brain Res. 764, 133-140.

Reiter, R.J. (1995). Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 9, 526-533.

Reiter, R.J., Tang, L., Garcia, J.J., and Munoz-Hoyos, A. (1997). Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci. 60, 2255-2271.


[Seite 95↓]

Reiter, R.J. (1998). Oxidative damage in the central nervous system: protection by melatonin. Prog. Neurobiol. 56, 359-384.

Rinner, W.A., Pifl, C., Lassmann, H., and Hörtnagl, H. (1997). The induction of apoptosis in vitro and in vivo by the cholinergic neurotoxin ethylcholine aziridinium. Neuroscience 79, 535-542.

Robinson, D., Friedman, L., Marcus, R., Tinklenberg, J., and Yesavage, J. (1994). Estrogen replacement therapy and memory in older women. J. Am. Geriatr. Soc. 42, 919-922.

Sakanaka M., Wen, T.C., Matsuda, S., Masuda, S., Morishita, E., Nagao, M., and Sasaki, R. (1998). In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. USA 95, 4635-4640.

Sampei, K., Goto, S., Alkayed, N.J., Crain, B.J., Korach, K.S., Traystman, R.J., Demas, G.E., Nelson, R.J., and Hurn, P.D. (2000). Stroke in estrogen receptor- α -deficient mice. Stroke 31, 738-744.

Saunders-Pullman, R., Gordon-Elliott, J., Parides, M., Fahn, S., Saunders, H.R., and Bressman, S. (1999). The effect of estrogen replacement on early Parkinson’s disease. Neurology 52, 1417-1421.

Savill, J., Fadok, V., Henson, P., and Haslett, C. (1993) Phagocyte recognition of cells undergoing apoptosis. Immunol. Today 14, 131-136.

Sawada, H., Ibi, M., Kihara, T., Urushitani, M., Akaike, A., and Shimohama, S. (1998). Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death. J. Neurosci. Res. 54, 707-719.

Sawada, H., Ibi, M., Kihara, T., Urushitani, M., Akaike, A., and Shimohama, S. (2000). Mechanisms of antiapoptotic effects of estrogens in nigral dopaminergic neurons. FASEB J. 14, 1202-1214.

Schwartz, L.M., Smith, S.W., Jones, M.E.E., and Osborne, B.A. (1993). Do all programmed cell deaths occur via apoptosis? Proc. Natl. Acad. Sci. USA 90, 980-984.

Sheldon, S.H. (1999). Pro-convulsant effects of oral melatonin in neurologically disabled children. Lancet 351, 1254.

Sherwin, B.B. (1994). Estrogenic effects on memory in women. Ann. N. Y. Acad. Sci. 743, 213-230.

Shi, J., Panickar, K.S., Yang, S.H., Rabbani, O., Day, A.L., and Simpkins, J.W. (1998). Estrogen attenuates over-expression of β -amyloid precursor protein messanger RNA in an animal model of focal ischemia. Brain Res. 810, 87-92.

Shughrue, P.J., Lane, M.V., and Merchenthaler, I. (1997). Comparative distribution of estrogen receptor- α and - β mRNA in the rat central nervous system. J. Comp. Neurol. 388, 507-525.

Singer, C.A., Rogers, K.L., Strickland, T.M., and Dorsa, D.M. (1996). Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci. Lett. 212, 13-16.

Singer, C.A., Figueroa-Masot, X.A., Batchelor, R.H., and Dorsa, D.M. (1999). The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J. Neurosci. 19, 2455-2463.

Skaper, S.D., Ancona, B., Facci, L., Franceschini, D., and Giusti, P. (1998). Melatonin prevents the delayed death of hippocampal neurons induced by enhanced excitatory neurotransmission and the nitridergic pathway. FASEB J. 12, 725-731.

Slee E.A., Adrain, C., and Martin S.J. (2001). Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J. Biol. Chem. 276, 7320-7326.

Southgate, G.S., Daya, S., and Potgieter, B. (1998). Melatonin plays a protective role in quinolinic acid-induced neurotoxicity in the rat hippocampus. J. Chem. Neuroanat. 14, 151-156.

Steller, H. (1995) Mechanisms and genes of cellular suicide. Science 267, 1445-1449.

Tan, D.X., Manchester, L.C., Reiter, R.J., Qi, W.B., Kim, S.J., and Elsokkary, G.H. (1998). Melatonin protects hippocampal neurons in vivo against kainic acid-induced damage in mice. J. Neurosci. Res. 54, 382-389.


[Seite 96↓]

Tang, M.X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H., and Mayeux, R. (1996). Effect of oestrogen during menopause on risk and age at onset of Alzheimer’s disease. Lancet 348, 429-432.

Teixeira, C., Reed, J.C., and Pratt, M.A. (1995). Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res. 55, 3902-3907.

Thompson, C.G. (1995). Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462.

Tieu, K., Zuo, D.M., and Yu, P.H. (1999). Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: Involvement of Bcl-2 and p53 proteins. J. Neurosci. Res. 58, 426-435.

Tsubata, T., Murakami, M., Nisitani, S., and Honjo, T. (1994). Molecular mechanisms for B lymphocyte selection: Induction and regulation of antigen-receptor-mediated apoptosis of mature B cells in normal mice and their defect in autoimmunity-prone mice. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 345, 297-301.

Uz, T., Giusti, P., Franceschini, D., Kharlamov, A., and Manev, H. (1996). Protective effect of melatonin against hippocampal DNA damage induced by intraperitoneal administration of kainate to rats. Neuroscience 73, 631-636.

Vanags, D.M., Porn-Ares, M.I., Coppola, S., Burgess, D.H., and Orrenius, S. (1996). Protease involvement in fodrin cleavage and phospatidylserine exposure in apoptosis. J. Biol. Chem. 271, 31075-31085.

Vaux, D.L., Haecker, G., and Strasser, A. (1994). An evolutionary perspective on apoptosis. Cell 76, 777-779.

Virchow, R. (1858). Cellular pathology based upon physiological and pathological histology. London: Curchill.

Walker, P.R., Kokileva, L., LeBlanc, J., and Sikorska, M. (1993). Detection of the initial stages of DNA fragmentation in apoptosis. Biotechniques 15, 1032-1040.

Wang, K.K.W. (2000). Calpain and caspase: can you tell the difference? Trends Neurosci. 23, 20-26.

Weaver, C.E. Jr., Park-Chung, M., Gibbs, T.T., and Farb, D.H. (1997). 17 β -Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res. 761, 338-341.

Wiesner, D.A., and Dawson, G. (1996). Staurosporine induces programmed cell death in embryonic neurons and activation of the ceramide pathway. J. Neurochem. 66, 1418-1425.

Williams, G.T. (1991). Programmed cell death: Apoptosis and oncogenesis. Cell 65, 1097-1098.

Wong, S.H.Y., Knight, J.A., Hopfer, S.M., Zaharia, O., Leach, C.N. Jr., and Sunderman, F.W. Jr. (1987). Lipoperoxides in plasma as measured by liquid-chromatography separation of malondialdehyde-thiobarbituric acid adduct. Clin. Chem. 33, 214-220.

Wyllie, A.H. (1980). Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284, 555-556.

Xu, H., Gouras, G.K., Greenfield, J.P., Vincent, B., Naslund, J., Mazzarelli, L., Fried, G., Jovanovic, J.N., Seeger, M., Relkin, N.R., Liao, F., Checler, F., Buxbaum, J.D., Chait, B.T., Thinakaran, G., Sisodia, S.S., Wang, R., Greengard, P., and Gandy, S. (1998). Estrogen reduces neuronal generation of Alzheimer β -amyloid peptides. Nat. Med. 4, 447-451.

Yaffe, K., Sawaya, G., Lieberburg, I., and Grady, D. (1998). Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 279, 688-695.

Yoneda, T., Imaizumi, K., Oono, K., Yui, D., Gomi, F., Katayama, T., and Tohyama, M. (2001) Activation of caspase 12, an endoplastic reticulum (RE) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress. J. Biol. Chem. 276, 13935-13940.


[Seite 97↓]

Zaulyanov, L.L., Green, P.S., Simpkins, J.W. (1999). Glutamate requirement for neuronal death from anoxia-reoxygenation: an in vitro model for assessment of the neuroprotective effects of estrogens. Cell. Mol. Neurobiol. 19, 705-718.

Zhang, L., Chang, Y.H., Barker, J.L., Hu, Q., Zhang, L., Maric, D., Li, B.S., and Rubinow, D.R. (2000). Testosterone and estrogen affect neuronal differentiation but not proliferation in early embryonic cortex of the rat: the possible roles of androgen and estrogen receptors. Neurosci. Lett. 281, 57-60.

Zheng, H., Xu, H., Uljon, S.N., Gross, R., Hardy, K., Gaynor, J., Lafrancois, J., Simpkins, J., Refolo, L.M., Petanceska, S., Whang, R., and Duff, K. (2002). Modulation of A(beta) peptides by estrogen in mouse models. J. Neurochem. 80, 191-196.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
18.04.2005